Log in or Sign up for Free to view tailored content for your specialty!
COPD News
COPD increases risk for sudden cardiac death
Chronic obstructive pulmonary disease is associated with increased risk for sudden cardiac death, especially in those with frequent exacerbations 5 years after diagnosis, according to new data from the Rotterdam study.
Nearly half the US population breathes unhealthy air
Approximately 138.5 million Americans, or almost 44%, currently live in areas where pollution levels often are considered too dangerous to breathe, according to the State of the Air 2015 report from the American Lung Association.
Log in or Sign up for Free to view tailored content for your specialty!
Blood eosinophil count predicts ICS response on COPD exacerbations
Patients with COPD and high blood eosinophil count experienced a greater benefit from the use of inhaled corticosteroids to reduce exacerbation frequency compared with patients with low eosinophil count, according to study results.
Hospitalizations for COPD exacerbations predicted greater mortality
Individuals with COPD exacerbations requiring hospitalization were common and considered a predictor of reduced survival across all COPD stages, according to study results.
ED visits, hospital discharges for COPD increase from 2001-2012
Total hospitalizations and ED visits from 2001 to 2012 for COPD have increased despite efforts to reduce COPD incidence, according to study results.
Discontinuing ICS therapy in COPD hastens decline in lung function
Lung function decline quickened during a 5-year follow-up in patients with moderate to severe COPD who ceased use of or sporadically maintained inhaled corticosteroid treatment after 30 months of therapy, according to study results.
ATS, ERS make recommendations for future COPD research
The American Thoracic Society and the European Respiratory Society have combined resources to issue a series of recommendations for the future of COPD research to attempt to determine the impact of COPD-related clinical practice guidelines on outcomes in patients with COPD.
Roflumilast increases PDE4B2 production, resulting in COPD patients developing a drug tolerance
The use of roflumilast in patients with COPD increases the production of a protein called PDE4B2, which may result in patients developing a tolerance to the drug after repeated use, according to study results published in the Proceedings of the National Academy of Sciences USA.
FDA finds no additional safety concerns with Breo Ellipta
GlaxoSmithKline’s Breo Ellipta showed no new safety concerns while being tested to treat asthma, according to a preliminary review from the FDA.
Researchers call for ban on tobacco sales by 2040
International experts are calling for the sale of tobacco to be phased out by 2040 and for governments to be proactive and institute strict policy to guide this process.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read